(Q48406851)

11 February 2018

title

Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers. (English)

1 reference

11 February 2018

1

Sandra D Comer

1 reference

11 February 2018

author name string

Maria A Sullivan

series ordinal

2

1 reference

11 February 2018

publication date

5 April 2007

1 reference

11 February 2018

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

11 February 2018

volume

193

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

235-245

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-007-0775-2

exact match

0 references

cites work

Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0775-2

Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0775-2

A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.

21 January 2018

1 reference

12 December 2020

NMDA antagonist modulation of morphine antinociception in female vs. male rats

1 reference

12 December 2020

Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614

1 reference

12 December 2020

The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor

1 reference

12 December 2020

Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice

1 reference

12 December 2020

Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward.

1 reference

12 December 2020

Dextromethorphan attenuates and reverses analgesic tolerance to morphine

1 reference

12 December 2020

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

1 reference

12 December 2020

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

1 reference

12 December 2020

Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat.

1 reference

12 December 2020

Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.

1 reference

12 December 2020

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

1 reference

12 December 2020

Effects of the NMDA antagonist memantine on human methamphetamine discrimination

1 reference

12 December 2020

Effects of smoking on rapid information processing performance

1 reference

12 December 2020

Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.

1 reference

12 December 2020

Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens

1 reference

12 December 2020

N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys

1 reference

12 December 2020

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

1 reference

12 December 2020

Memantine: update on the current evidence

1 reference

12 December 2020

Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade

1 reference

12 December 2020

Reinstatement of morphine-conditioned reward is blocked by memantine

1 reference

12 December 2020

Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.

1 reference

12 December 2020

NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference.

1 reference

12 December 2020

Acute effects of memantine in combination with alcohol in moderate drinkers.

1 reference

12 December 2020

Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence

1 reference

12 December 2020

Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes

1 reference

12 December 2020

The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans.

1 reference

12 December 2020

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

12 December 2020

Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test.

1 reference

12 December 2020

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

1 reference

12 December 2020

Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.

1 reference

12 December 2020

Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.

1 reference

12 December 2020

The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans

1 reference

12 December 2020

Two New Rating Scales for Opiate Withdrawal

1 reference

12 December 2020

Dextromethorphan differentially affects opioid antinociception in rats.

1 reference

12 December 2020

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1 reference

12 December 2020

Effects of NMDA receptor antagonists on acute μ-opioid analgesia in the rat

1 reference

12 December 2020

Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans

1 reference

12 December 2020

Behavioral and subjective effects of DN-2327 (pazinaclone) and alprazolam in normal volunteers

1 reference

12 December 2020

Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan

1 reference

12 December 2020

Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice

1 reference

12 December 2020

Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation.

1 reference

12 December 2020

An evaluation of the reinforcing effects of memantine in cocaine-dependent humans

1 reference

12 December 2020

10.1007/S00213-007-0775-2

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

17406858

1 reference

11 February 2018